Navigation Links
Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
Date:5/17/2013

ncurrent administration of monoamine oxidase inhibitors (MAOI) or administration of Vyvanse within 14 days of the last MAOI dose. Hypertensive crisis can occur.
  • Educate patients about abuse and periodically re-evaluate the need for Vyvanse.
  • Sudden death, stroke and myocardial infarction have been reported in adults with CNS stimulant treatment at recommended doses. Sudden death has been reported in children and adolescents with structural cardiac abnormalities and other serious heart problems taking CNS stimulants at recommended doses for ADHD. Prior to treatment assess for the presence of cardiac disease. Avoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart arrhythmia, coronary artery disease, and other serious heart problems. Further evaluate patients who develop exertional chest pain, unexplained syncope, or arrhythmias during Vyvanse treatment.
  • CNS stimulants cause an increase in blood pressure (mean increase about 2-4 mm Hg) and heart rate (mean increase about 3-6 bpm). Monitor all patients for tachycardia and hypertension.
  • Use of stimulants may cause psychotic or manic symptoms in patients with no prior history, or exacerbation of symptoms in patients with preexisting psychosis. Clinical evaluation for bipolar disorder is recommended prior to stimulant use.
  • CNS stimulants have been associated with weight loss and slowing of growth rate in pediatric patients. Monitor weight and height in children during treatment with Vyvanse. Treatment may need to be interrupted in children not growing as expected.
  • The most common adverse reactions (≥5% and at least twice the rate of placebo) reported in clinical trials were:    
    • Children aged 6 to 12: decreased appetite, insomnia, upper abdominal pain, irritability, vomiting, decreased weight, nausea, dry mouth and dizziness;
    • Adolescen
      '/>"/>

    SOURCE Shire plc
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
    2. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
    3. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
    4. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
    5. Shire Second Quarter Product Sales Up 16%
    6. Dr Steven Gillis to Join Shire Board of Directors
    7. Shire Leads New Initiative to Reveal Challenges Facing Rare Disease Community
    8. NYSE Hot Stocks Earnings Forecast: Wells Fargo, Eli Lilly, Berkshire Hathaway, Coca-Cola, Valero Energy, and Altria Group
    9. Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its Complications
    10. Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013
    11. Shire Supports Rare Disease Day 2013
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... , July 29, 2014   ... II study investigating the efficacy and safety of MSB0010718C in ... is a rare and aggressive skin cancer lacking effective treatments   ... seven cohort Phase I clinical trial for the treatment of ... EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ...
    (Date:7/28/2014)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) ... audio webcast to discuss financial results for the second quarter ... 31, 2014 at 4:30 p.m. ET. Conference ... 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the Pharmacyclics ...
    (Date:7/28/2014)... FRANCISCO , July 28, 2014  Dignity ... it has received the Get With The Guidelines®-Stroke ... improvement measures outlined by the American Heart Association/American ... Stroke is the number four cause of death ... the United States , according ...
    Breaking Medicine Technology:EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3
    ... 17 Mach 7 Technologies, a global provider of ... product distribution agreement with Data Distributing, an international leader ... the medical industry. Under the terms of the agreement, ... an Enterprise Image Management Platform, in the United States. ...
    ... , , ALISO VIEJO, Calif., Nov. ... executives from over 425 companies to discuss promising technology and ... the 4th Annual CA Medical Device & Investor Forum. ... from the biggest M&A transactions in Orange County history discussed ...
    Cached Medicine Technology:Mach 7 Technologies and Data Distributing Sign Agreement for U.S. Distribution of Enterprise Image Management Solutions 2OCTANe's Medical Device & Investor Forum Highlights Key Trends, Investment Opportunities 2
    (Date:7/28/2014)... 2014 A leading proposal to temporarily ... trust fund by reallocating payroll taxes has virtually no ... The Senior Citizens League (TSCL) . Less ... from the Social Security retirement trust fund to pay ... disability program’s financing. “TSCL believes this ‘band aid’ approach ...
    (Date:7/28/2014)... The “Tissue Diagnostics Market by ... & Workflow, Special Staining), Disease (Breast Cancer, ... Cell Lung Cancer and Others), Product (Instruments ... Laboratories, Contract Research Organizations and Others) & ... & RoW) - Trends & Forecast to ...
    (Date:7/28/2014)... A January 2013 study published ... in those who were self-diagnosed gluten-intolerant yielded little verifiable ... for San Diego health and wellness retreat VeraVia ... those who are unclear about the role gluten plays ... a protein, found in wheat, barley, rye, and triticale. ...
    (Date:7/28/2014)... HealthDay Reporter MONDAY, July 28, ... milliseconds to look at someone,s face and judge them good-looking ... certain facial features seem to trigger specific first impressions about ... the mouth, for example, appear directly linked to whether someone ... The study findings suggest that first impressions are fairly ...
    (Date:7/28/2014)... Shofner Vision Center recently wrapped ... Renowned LASIK and Cataract Surgeon, Dr. Stewart Shofner ... and public awareness for local not-for-profit organizations that ... their families. “This was our 2nd annual summer ... to a variety of local not-for-profit organizations who ...
    Breaking Medicine News(10 mins):Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 2Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 3Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 2Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 3Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 4Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 5Health News:VeraVia Explains the Basics of Gluten-Intolerance Following Industry Study 2Health News:VeraVia Explains the Basics of Gluten-Intolerance Following Industry Study 3Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3
    ... CHICAGO Jorge Sobenes is a husband and father who loves ... he went from enjoying his favorite foods to not being able ... and difficulty swallowing. He lost 40 pounds and was desperate ... the esophagus is unable to move food into the stomach, and ...
    ... with hepatocellular carcinoma (HCC) is achievable using 90Y-resin ... across Europe showed that the procedure is likely ... including patients with advanced liver cancer and with ... to dateare published in the September issue of ...
    ... -- An experimental drug that,s shown promise against ovarian cancer ... also be effective against ovarian cancer not caused by those ... the activity of a protein called poly ADP ribose polymerase ... repair. Clinical trials of olaparib in patients with BRCA 1 ...
    ... HealthDay Reporter , MONDAY, Aug. 22 (HealthDay News) -- ... also appears linked to a decline in mammograms, new research ... 50 to 64 reduced their hormone therapy use from 41 ... study lead author Nancy Breen, an economist with the U.S. ...
    ... can act as "weight shocks," leading people to add a few ... to a new study. But when it comes to large ... men than they are for women. For men, the risk ... But for women, the risk of a large weight gain was ...
    ... HealthDay Reporter , SATURDAY, Aug. 20 (HealthDay News) -- Working ... stay-at-home moms, a new study finds. However, working moms ... about how easy it will be to balance work and ... counterparts. , , Researchers analyzed survey results from 1,600 married ...
    Cached Medicine News:Health News:Incisionless surgery now available as an investigational treatment for esophageal disorder 2Health News:Radioembolization improves chance of survival for liver cancer patients 2Health News:Trial Drug Shows Preliminary Promise Against Ovarian Cancer 2Health News:Decline in Hormone Therapy Linked to Fewer Mammograms 2Health News:Large weight gains most likely for men after divorce, women after marriage 2Health News:Large weight gains most likely for men after divorce, women after marriage 3Health News:Trying to Be 'Supermom' Can Raise Risk for Depression 2Health News:Trying to Be 'Supermom' Can Raise Risk for Depression 3
    This is adapted to microplate or card....
    Bio-Rad's ScanGel® cards for blood typing provide standardized protocols for all the cards: same incubation time (if required), same centrifugation time and speed....
    Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
    ... cell accommodates up to 12 large slab ... in the PROTEAN IEF system, for high-throughput ... PROTEAN Plus Dodeca cell's cooling and recirculating ... consistent, high-resolution results. The handcasting system includes ...
    Medicine Products: